This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Defense Sticks by Overseas Drug Policy.—
The Defense Department said it will not change its policy of buying drugs overseas despite the indictment of eight men accused of conspiring to steal antibiotic drug cultures and shipping them to Italy.The Defense Agency's stand, first reported in the AMA News, was the latest development in a running controversy between the drug industry and the Defense Department concerning purchase of foreign drugs that infringe on US patents.It has been known since 1959, that Italian firms were producing tetracycline and tetracycline-type drugs that were patented in this country and were not licensed for sale by the Italian companies. But not until the indictment by a federal grand jury in New York, has any action been taken in this country.The indictment last month accused the eight men of conspiring to steal cultures of tetracycline from Lederle Laboratories in Pearl River, N.Y., and
WASHINGTON NEWS. JAMA. 1962;182(7):33–35. doi:10.1001/jama.1962.03050460115024
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: